Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Quality of Life in Greek Hemodialysis Patients Receiving Zemplar i.v (QualitiZe)

NCT01368042 is registered in ClinicalTrials.gov with AbbVie (prior sponsor, Abbott) as lead sponsor.

NCT NCT01368042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01368042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Quality of Life in Greek Hemodialysis Patients Receiving Zemplar i.v (QualitiZe)
Lead sponsor
AbbVie (prior sponsor, Abbott)
Phase
Observational
Overall status
Completed
Start date
August 31, 2011
Completion date
June 30, 2013
Enrollment
265 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

chronic kidney disease, secondary hyperparathyroidism